TO ASSESS EFFICACY OF ERANDA KSHAR YOGA AND TRYUSHNADI GUGGULU IN THE MANAGEMENT OF MEDOROGA W.S.R. TO DYSLIPIDEMIA
- Conditions
- Health Condition 1: - Health Condition 2: E785- Hyperlipidemia, unspecified
- Registration Number
- CTRI/2021/04/032552
- Lead Sponsor
- Ayurvedic and Unani Tibbia College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
a) Patients between the age group of 18-60 years of either sex.
b) Willing and able to participate in the study for 90 days.
c) Patients having Serum Cholesterol 201-400mg/dl, Serum Triglycerides 151- 400 mg/dl LDL Cholesterol 131-250 mg/dl, HDL Cholesterol <40mg/dl.
d)Patients with strictly controlled Diabetes Mellitus (HbA1c less than or equal to 7%)
Patients having medical history of-
a)Patients who have a past history of Atrial Fibrillation, Acute Coronary Syndrome, Myocardial Infarction, congestive heart failure, Stroke or severe Arrhythmia, Unstable angina in the last six months.
b)Patients on prolonged ( >6weeks) medication with corticosteroids, antidepressants, anticholinergics, immunosuppressant, estrogen replacement therapy etc. or any other drugs that may have an influence on the outcome of the study and patients on oral contraceptives.
c)Patients with poorly controlled hypertension (systolic >140 and diastolic >90 mm of Hg) despite of antihypertensive agents.
d)Patients with evidence of malignancy.
e)Hypersensitivity to any of the trial drugs or their ingredients.
f)Patients who have completed participation in any other clinical trial drugs or their ingredients in one -month period.
g)Patients who have received any cholesterol lowering medication (allopathic drug) within last two weeks.
h)Pregnancy and Lactating mother.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the clinical efficacy of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.Timepoint: 3 Months
- Secondary Outcome Measures
Name Time Method To evaluate the safety of Tryushnadi Guggulu and Eranda kshar yoga in management of dyslipidemia.Timepoint: 90 Days